Patents Assigned to Taipei Medical University
  • Publication number: 20080311059
    Abstract: A skin whitening composition and a method for the same are provided. The skin whitening composition comprises a far-infrared ray releasing substance having a primary component of an oxide mineral, wherein the skin whitening composition achieves a whitening effect via an irradiation of the far-infrared ray releasing substance. In another aspect, the method comprises the steps of administering a far-infrared ray releasing substance to a subject and reducing melanogenesis of the subject by inhibiting growth of a pigment cell, wherein the far-infrared releasing substance has an oxide mineral.
    Type: Application
    Filed: September 18, 2007
    Publication date: December 18, 2008
    Applicants: NATIONAL APPLIED RESEARCH LABORATORIES, TAIPEI MEDICAL UNIVERSITY
    Inventors: Yung-Sheng LIN, Ming-Yu LIN, Tsung-Tao Huang, Ting-Kai Leung, Chwen-Ming SHIH
  • Publication number: 20080258351
    Abstract: An electrospinning equipment is provided. The electrospinning equipment includes a power supply, a collector and a material supply electrically connected to the power supply facing the collector and having a spinneret and a guide unit coupled to the spinneret and bent toward the collector, and the spinneret is configured at a central portion of the guide unit.
    Type: Application
    Filed: October 23, 2007
    Publication date: October 23, 2008
    Applicants: NATIONAL APPLIED RESEARCH LABORATORIES, TAIPEI MEDICAL UNIVERSITY
    Inventors: Kuen-Wey Shieh, Chien-Chung Chen, Yung-Sheng Lin
  • Publication number: 20080217163
    Abstract: A manufacturing method for a far-infrared (FIR) substrate is provided. The manufacturing method includes steps of providing a substrate and sputtering a FIR emission material onto at least one surface of the substrate to form a thin film.
    Type: Application
    Filed: January 4, 2008
    Publication date: September 11, 2008
    Applicants: NATIONAL APPLIED RESEARCH LABORATORIES, TAIPEI MEDICAL UNIVERSITY
    Inventors: Yung-Sheng Lin, Han-Chang Pan, Chao-Te Lee, Ting-Kai Leung
  • Patent number: 7399598
    Abstract: The present invention relates to a non-invasive diagnosis method of endometriosis by detecting biochemical marker in serum or peritoneal fluid, in particular alpha 1-antitrypsin, fragments of alpha 1-antitrypsin, or a combination of both. The diagnosis of endometriosis is performed with observing in serum specimens of a patient the concentration and change of the biochemical marker, in particular molecules related to alpha 1-antitrypsin, and comparing with a predetermined baseline level of the biochemical marker contained in serum. Statistical analysis can be performed to evaluate the baseline level indicating the occurrence of endometriosis. Therefore, the present invention can provide an auxiliary guideline for the diagnosis of endometriosis. The present invention also relates to usage of the biochemical marker.
    Type: Grant
    Filed: October 14, 2005
    Date of Patent: July 15, 2008
    Assignee: Taipei Medical University
    Inventors: Wei-Chung Yang, Chii-Ruey Tzeng, Hwei-Jiung Wang
  • Publication number: 20080096973
    Abstract: A series of Z-stilbenes derivatives are disclosed, which have the structure as shown by formula 1. In the structure of formula 1, X is hydrogen, NHR, or nitro group, and R is hydrogen. Y and Z is independently hydrogen, halogen, C1-C10 alkyl, or C1-C10 alkoxyl. Furthermore, A is hydrogen, hydroxyl, or amino group. The compounds of the present invention have both aqueous solubility and anti-tumor activity. The Z-stilbenes derivatives of the present invention can further include a pharmaceutical carrier to form pharmaceutical compositions as potent anti-mitotic agents and anti-cancer agents.
    Type: Application
    Filed: January 19, 2007
    Publication date: April 24, 2008
    Applicants: Taipei Medical University, National Health Research Institutes
    Inventors: Jing-Ping Liou, Jang-Yang Chang
  • Publication number: 20080058386
    Abstract: A series of indoline-sulfonamide compounds is disclosed. The formula of indoline-sulfonamide compounds is shown as formula (I). In formula (I), R1 is H or halogen; R2 is Ar, Ar—C(O)—, Ar—CH2—, Ar—SO2—, Ar—O—C(O), or R?—C(O)—, and Ar is a substituted or unsubstituted C5-C20 aryl, cyclyl, heterocyclyl, or heteroaryl, R? and R? independently is C1-C10 alkyl, or C1-C10 alkoxyl; and R3 is C5-C15 aryl or C1-C10 alkyl. The indoline-sulfonamide compounds disclosed in the present invention are characterized in inhibiting tubulin polymerization, and treating cancers and other tubulin polymerization-related disorders with a suitable pharmaceutical acceptable carrier.
    Type: Application
    Filed: May 10, 2007
    Publication date: March 6, 2008
    Applicants: Taipei Medical University, National Health Research Institutes
    Inventors: Jing-Ping Liou, Jang-Yang Chang, Hsing-Pang Hsieh
  • Publication number: 20070191741
    Abstract: Image analysis methods for gleno-humeral joint morphology. At least one specific structure is approximated as an elliptical structure at a plurality of transverse sections. At least one pathological feature on the structure is recognized. At least one structural spatial property of a 3D structure is calculated based on the structural property of the elliptical structure, thus determining the morphology of the 3D structure. Structural deformities are evaluated according to the morphology of the 3D structure. The pathological features on the sections are integrated to obtain at least one 3D pathological feature property, and a treatment is determined accordingly.
    Type: Application
    Filed: July 19, 2006
    Publication date: August 16, 2007
    Applicants: CHUNG YUAN CHRISTIAN UNIVERSITY, TAIPEI MEDICAL UNIVERSITY
    Inventors: Ming-Dar Tsai, Ming-Shium Hsieh
  • Publication number: 20070087097
    Abstract: This invention discloses a method for making rice bran flour by treating rice bran under high pressure and high temperature for a long period of time in two separate steps, the method comprising: husking and grinding the rice, then collecting the rice bran; inactivating the lipase of the rice bran; treating the rice bran under high pressure and high temperature; drying and screening the rice bran; treating the rice bran flour so obtatined under high pressure and high temperature again; and cooling the rice bran. Said rice bran flour made from said method is effective in lowering glycosylated hemoglobin and increasing insulin of diabetes mellitus patients.
    Type: Application
    Filed: October 19, 2005
    Publication date: April 19, 2007
    Applicant: TAIPEI MEDICAL UNIVERSITY
    Inventor: Hsing-Hsien Cheng
  • Patent number: 7121832
    Abstract: A three-dimensional surgery simulation system is provided for generating a three-dimensional surgery simulation result of an anatomical part undergoing a simulated surgical procedure. The system includes a display unit, a three-dimensional visual imaging unit, a storage unit for storing a plurality of voxelized three-dimensional model image data sets, an input unit for controlling progress of the simulated surgical procedure, and a computing unit for computing the simulation result data in accordance with the voxelized three-dimensional model image data sets and under the control of the input unit, and for controlling the display unit to permit viewing of the surgery simulation result in three-dimensional form thereon by an operator wearing the visual imaging unit.
    Type: Grant
    Filed: March 4, 2003
    Date of Patent: October 17, 2006
    Assignee: Taipei Medical University
    Inventors: Ming-Shium Hsieh, Ming-Dar Tsai
  • Publication number: 20060229358
    Abstract: A pharmaceutical composition is provided, where the pharmaceutical composition contains formula (I), (II), or (III) flavonoids which possess selective phosphodiesterase 4 or 4/3 inhibition, as a main ingredient. Especially, this composition is used in the treatment of asthma, chronic obstructive pulmonary disease (COPD), or chronic inflammation, and has bronchodilatory effects. In addition, whether the above-mentioned flavonoids have side effects, such as nausea, vomiting, gastric hypersecretion, etc., in accordance with their binding to high affinity rolipram binding sites (HARBS) of particulates of brain cells are disclosed.
    Type: Application
    Filed: April 4, 2006
    Publication date: October 12, 2006
    Applicant: Taipei Medical University
    Inventor: Wun-Chang Ko